Search for: "White v. S&H Marketing Inc." Results 61 - 80 of 104
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jul 2008, 7:04 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
24 Mar 2024, 9:01 pm by renholding
Jack’s paper was called “Market Failure and the Economic Case for a Mandatory Disclosure System. [read post]
21 Nov 2011, 1:50 pm by Geoffrey Rapp
The Second Circuit invalidates the FCC’s indecency policy in Fox Television Stations, Inc. v. [read post]
19 Mar 2022, 2:09 pm by admin
The FDA’s M7 Guidance observes that “[s]tandard risk assessments of known carcinogens assume that cancer risk increases as a function of cumulative dose. [read post]
14 Jan 2015, 10:05 am
  These questions, among others, find a response in yesterday's judgment of High Court for England and Wales, Chancery Division, ruling of Mr Justice Arnold in Enterprise Holdings Inc v Europcar Group UK and Another[2015] EWHC 17 (Ch).BackgroundEnterprise and Europcar are two heavyweights of the car rental market. [read post]
30 Jun 2019, 4:07 pm by INFORRM
Readers are reminded that the consultation on the Government’s Online Harms White paper closes at 23:59, 1 July 2019. [read post]
27 Jun 2008, 10:04 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
17 Sep 2011, 11:39 pm by David Kopel
Diamond, “Never Intended to Be Applied to the White Population”: Firearms Regulation and Racial Disparity—The Redeemed South’s Legacy to a National Jurisprudence? [read post]
15 Feb 2008, 9:00 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
“It’s not easy being green”: local incentives, preemption problems, and the market participation exception. 78 U. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), … [read post]